Sign in

CIK 0001625297

  • Large accelerated filer

Supernus, Inc.

Sign in to watch
Tickers
INDV SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412520873
Phone
+1 804-379-1090
Business address
9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Former names
Indivior Pharmaceuticals, Inc., INDIVIOR PLC

Securities

  • INDV Common stock Nasdaq
  • SUPN Common Stock Nasdaq
Open-market buys, last 90 days
$53,535
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$53,535. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Anderson Woodrow D +$54K Chief Accounting Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-06-08 Preblick Ryan Chief Financial Officer Sale 10b5-1 −36,000 $37.70 $1.4M 284,751
2026-03-14 Preblick Ryan Chief Financial Officer Option exercise +6,302 323,594
2026-03-14 Preblick Ryan Chief Financial Officer Shares withheld for taxes −2,843 $31.11 $88K 320,751
2026-03-14 Preblick Ryan Chief Financial Officer Option exercise · Restricted Stock Units −6,302 0
2026-03-03 Preblick Ryan Chief Financial Officer Shares withheld for taxes −87,597 $31.98 $2.8M 230,343
2026-03-03 Preblick Ryan Chief Financial Officer Option exercise +86,949 317,292
2026-03-03 Preblick Ryan Chief Financial Officer Option exercise · Performance Stock Units −113,510 0
2026-02-10 Preblick Ryan Chief Financial Officer Grant or award +37,358 317,940
2026-02-09 Preblick Ryan Chief Financial Officer Grant or award · Performance Stock Units +113,510 113,510

Page 1 of 1 · 9 trades